Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 11
Submit an article Journal homepage
957
Views
27
CrossRef citations to date
0
Altmetric
Review

Does heart failure exacerbation increase response to warfarin?A critical review of the literature

Timothy H. Self College of Pharmacy, University of Tennessee Health Science Center; Methodist University Hospital, Memphis, TN, USACorrespondence[email protected]
,
Anne B. Reaves College of Pharmacy, University of Tennessee Health Science Center; Methodist University Hospital, Memphis, TN, USA
,
Carrie S. Oliphant College of Pharmacy, University of Tennessee Health Science Center; Methodist University Hospital, Memphis, TN, USA
&
Chris Sands College of Medicine, University of Tennessee Health Science Center; Methodist University Hospital, Memphis, TN, USA
Pages 2089-2094 | Accepted 16 Aug 2006, Published online: 21 Sep 2006

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Timothy H. Self, Ryan E. Owens, Sami A. Sakaan, Jessica L. Wallace, Christopher W. Sands & Amanda Howard-Thompson. (2016) Effect of diseases on response to vitamin K antagonists. Current Medical Research and Opinion 32:4, pages 613-620.
Read now
Jeremy P. Berman & Jonathan L. Halperin. (2013) Novel Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation. Hospital Practice 41:1, pages 37-48.
Read now
Heather D Edwards, Ryan D Webb & Susan E Conway. (2012) Effect of oral diuretics on chronic warfarin therapy: a retrospective study. Expert Opinion on Drug Safety 11:3, pages 375-380.
Read now

Articles from other publishers (24)

Thomas Schlöglhofer, Angelika Marschütz, Pamela Combs, Corinne Stonebraker, Sydney Lupo, Valluvan Jeevanandam, Julia Riebandt, Heinrich Schima, Daniel Zimpfer & Karen Meehan. (2023) Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study. ASAIO Journal 69:6, pages 595-601.
Crossref
Thomas Schlöglhofer, Lydia Zapusek, Dominik Wiedemann, Julia Riebandt, Franziska Wittmann, Kamen Dimitrov, Philipp Angleitner, Lisa Haberl, Günther Laufer, Francesco Moscato, Daniel Zimpfer & Heinrich Schima. (2020) International Normalized Ratio Test Frequency in Left Ventricular Assist Device Patients Affects Anticoagulation Quality and Adverse Events. ASAIO Journal 67:2, pages 157-162.
Crossref
Christina E. DeRemer, Bliss McMichael & Henry N. Young. (2018) Warfarin Patients With Anemia Show Trend of Out-of-Range International Normalized Ratio Frequency With Point-of-Care Testing in an Anticoagulation Clinic. Journal of Pharmacy Practice 32:5, pages 499-502.
Crossref
Enrique Santas, Gema Miñana, Jana Gummel, Roxana Farcasan, Ana Payá, Raquel Heredia, Vicent Bodí, Anna Mollar, Vicente Bertomeu-González, Francisco Javier Chorro, Juan Sanchis, Josep Lupón, Antoni Bayés Genís & Julio Núñez. (2019) Razón internacional normalizada y mortalidad de los pacientes con insuficiencia cardiaca y fibrilación auricular tratados con antagonistas de la vitamina K. Revista Española de Cardiología 72:8, pages 616-624.
Crossref
Enrique Santas, Gema Miñana, Jana Gummel, Roxana Farcasan, Ana Payá, Raquel Heredia, Vicent Bodí, Anna Mollar, Vicente Bertomeu-González, Francisco Javier Chorro, Juan Sanchis, Josep Lupón, Antoni Bayés Genís & Julio Núñez. (2019) International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists. Revista Española de Cardiología (English Edition) 72:8, pages 616-624.
Crossref
Paul P. Dobesh & Zachary A. Stacy. 2019. Stroke Prevention in Atrial Fibrillation. Stroke Prevention in Atrial Fibrillation 11 34 .
Karen Tyson, Nevil Hutchinson, Sian Williams & Greg Scutt. (2018) Identification of clinical factors predicting warfarin sensitivity after cardiac surgery. Therapeutic Advances in Drug Safety 9:8, pages 415-424.
Crossref
Brandon K. Martinez, Brenda Yik, Raymond Tran, Sabrina Ilham, Craig I. Coleman, Douglas L. Jennings & William L. Baker. (2018) Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin. Artificial Organs 42:7, pages 700-704.
Crossref
Israel Gotsman, Orly Ezra, Bruria Hirsh Raccah, Dan Admon, Chaim Lotan & Freda Dekeyser Ganz. (2017) Patient-Specific Tailored Intervention Improves INR Time in Therapeutic Range and INR Variability in Heart Failure Patients. The American Journal of Medicine 130:8, pages 982-989.
Crossref
Christopher J. Arendt, Joon Hwa Hong, Richard C. Daly, Christopher Scott, Ramila A. Mehta, Kent Bailey, Jyotishman Pathak & Naveen L. Pereira. (2017) Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery. American Heart Journal 187, pages 70-77.
Crossref
Xiaowei Gong, Haiyan Wang & Yadong Yuan. (2016) Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism. Experimental and Therapeutic Medicine 12:4, pages 2265-2274.
Crossref
Martin A. Bishop & Michael B. Streiff. (2016) Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients. Journal of Thrombosis and Thrombolysis 42:2, pages 283-287.
Crossref
Mahmoud I. Abdel-Aziz, Mostafa A. Sayed Ali, Ayman K.M. Hassan & Tahani H. Elfaham. (2015) Factors influencing warfarin response in hospitalized patients. Saudi Pharmaceutical Journal 23:6, pages 642-649.
Crossref
Michaela del Campo & Greg Roberts. (2015) Changes in Warfarin Sensitivity During Decompensated Heart Failure and Chronic Obstructive Pulmonary Disease. Annals of Pharmacotherapy 49:9, pages 962-968.
Crossref
Lauren B. Cooper & Adrian F. Hernandez. (2015) Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure. Heart Failure Clinics 11:3, pages 499-506.
Crossref
Agnes Rouaud, Olivier Hanon, Anne-Sophie Boureau, Guillaume Gilles Chapelet & Laure de Decker. (2015) Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study. PLOS ONE 10:3, pages e0119043.
Crossref
Timothy H. Self, Carrie S. Oliphant, Anne B. Reaves, Amy M. Richardson & Christopher W. Sands. (2015) Fever as a Risk Factor for Increased Response to Vitamin K Antagonists: A Review of the Evidence and Potential Mechanisms. Thrombosis Research 135:1, pages 5-8.
Crossref
Freek W. A. Verheugt. (2013) Advances in Stroke Prevention in Atrial Fibrillation: Enhanced Risk Stratification Combined With the Newer Oral Anticoagulants. Clinical Cardiology 36:6, pages 312-322.
Crossref
Walter Ageno, Alexander S. Gallus, Ann Wittkowsky, Mark Crowther, Elaine M. Hylek & Gualtiero Palareti. (2012) Oral Anticoagulant Therapy. Chest 141:2, pages e44S-e88S.
Crossref
B. Cryder, M. Felczak, J. Janociak, L. Dela Pena, S. Allen & P. Gutierrez. (2011) Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics. Journal of Clinical Pharmacy and Therapeutics 36:1, pages 64-70.
Crossref
Pamela J. White. (2010) Patient Factors That Influence Warfarin Dose Response. Journal of Pharmacy Practice 23:3, pages 194-204.
Crossref
Toni L. Ripley, Donald Harrison, Robin E. Germany & Philip B. Adamson. (2010) Effect of heart failure exacerbations on anticoagulation: A prospective, observational, pilot cohort study. Clinical Therapeutics 32:3, pages 506-514.
Crossref
Anil Gopinath & Thomas R. Gildea. 2010. Current Clinical Medicine. Current Clinical Medicine 1077 1083.e1 .
Jennifer Bird & Carlos Carmona. (2008) Probable Interaction Between Warfarin and Torsemide. Annals of Pharmacotherapy 42:12, pages 1893-1898.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.